KATHERINE STULL: Open Payments
NPI 1194276493 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 15 payments from 6 companies in 2025. Trend: 2023 $171 · 2024 $448 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $252 |
| Insmed, Inc. | 1 | $132 |
| GlaxoSmithKline, LLC. | 4 | $90 |
| Verona Pharma, Inc. | 2 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
Products named: FASENRA, Arikayce, Ohtuvayre, DUPIXENT, NUCALA, TRELEGY ELLIPTA, JASCAYD, OFEV.
Industry payments across PA — which companies pay providers there.
